Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

2022 Minority Hematology Fellow Award

December 12, 2022

Currently in its third cohort, the Minority Hematology Fellow Award (MHFA) succeeds MRHAP in the pathway and precedes the ASH-AMFDP. It encourages early-career researchers (MD/DO, PhD, and MD/ DO-PhD) from historically under-represented minority groups in the United States and Canada to pursue a career in academic hematology and provides salary support as well as funds to support hematology focused research projects. MHFA is designed to retain fellows in hematology.

ASH congratulates nine MHFA winners this year.



Owhofasa Agbedia, MD, MPH — The University of Texas MD Anderson Cancer Center; Targeting Aggressive NK-cell Leukemia and Other CD94- expressing NK/T-cell Lymphoproliferative Disorders With Anti-CD94 CAR T-cell Therapy; Mentor: Sattva Neelapu, MD

Juan Carlos Balandran, PhD — NYU Grossman School of Medicine; The Role of Inflammation in Emergency Hematopoiesis and Blood Malignancy; Mentor: Iannis Aifantis, PhD

Britney Bell, MD — Boston Medical Center; Integration of Health Literacy Universal Precautions Into Clinical Practice as a Strategy to Improve Patient- Reported Outcomes in Patients With Hematologic Malignancies and Limited English Proficiency; Mentor: Camille Edwards, MD

Eden Biltibo, MD — Vanderbilt University Medical Center; Impact of Daratumumab in the Treatment of Vulnerable Transplant Eligible Multiple Myeloma Patients and Its Utilization in Blacks; Mentor: Adetola Kassim, MD, MBBS

Gerard Hills, MD — Indiana University School of Medicine; Using Artificial Intelligence to Predict Early Death in Patients With Sickle Cell Disease in a National Cerner Database; Mentor: Michael DeBaun, MD, MPH

Olufunke Martin, MD — Children’s National Hospital; Investigating Risk Factors Associated with Thrombosis in Sickle Cell Disease; Mentor: Arun Shet, MD, PhD

Walatta-Tseyon Mesquitta, PhD — Boston Children’s Hospital, Harvard Medical School; Identifying and Characterizing Cellular Trajectories With T-cell Fate Potential That Emerge From hPSC Definitive Mesoderm; Mentor: Fernando Camargo, PhD

Chijioke Nze, MD, MPH — The University of Texas MD Anderson Cancer Center; Assessing Barriers to Enrollment of Minority Patients in Therapeutic Lymphoma Clinical Trials; Mentor: Christopher Flowers, MD

Luisanna Sanchez Ventura, MD — Baylor College of Medicine; Clinical and Molecular Profiles Associated With Robust and Sustained Hydroxyurea Response for Patients With Sickle Cell Disease; Mentor: Jonathan M. Flanagan, PhD


Close Modal

or Create an Account

Close Modal
Close Modal